Clinical Introduction of Stem Cell Sparing Radiotherapy to Reduce the Risk of Xerostomia in Patients with Head and Neck Cancer
2024

Reducing Dry Mouth in Head and Neck Cancer Patients with Stem Cell Sparing Radiotherapy

Sample size: 30 publication 10 minutes Evidence: high

Author Information

Author(s): van Rijn-Dekker Maria I., van der Schaaf Arjen, Nienhuis Sanne W., Arents-Huls Antoinette S., Ger Rachel B., Hamming-Vrieze Olga, Hoebers Frank J. P., de Ridder Mischa, Vigorito Sabrina, Zwijnenburg Ellen M., Langendijk Johannes A., van Luijk Peter, Steenbakkers Roel J. H. M.

Primary Institution: University Medical Centre Groningen, University of Groningen

Hypothesis

Can stem cell sparing radiotherapy be effectively adopted in routine clinical practice to reduce the risk of xerostomia in head and neck cancer patients?

Conclusion

Stem cell sparing radiotherapy can be clinically introduced with minor adjustments to existing optimization strategies and can reduce the risk of xerostomia after treatment.

Supporting Evidence

  • Stem cell sparing radiotherapy reduced the mean dose to stem cell rich regions significantly.
  • Patients experienced lower normal tissue complication probabilities for xerostomia.
  • Adjustments to optimization strategies were minimal and effective across multiple centers.

Takeaway

This study shows that a special type of radiation therapy can help patients with head and neck cancer avoid a dry mouth after treatment.

Methodology

The study involved multiple planning studies comparing stem cell sparing radiotherapy with standard radiotherapy in 30 head and neck cancer patients, assessing dose reductions and side effects.

Potential Biases

Inter-RTT variation may have affected observed dose differences.

Limitations

The use of manually made treatment plans may have introduced variability in results, and the study was not designed to assess oncological outcomes.

Participant Demographics

{"sex":{"female":11,"male":19},"age":{"median":69,"range":"36-85"},"tumor_location":{"oropharynx":9,"nasopharynx":6,"larynx":5,"hypopharynx":5,"oral_cavity":5}}

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3390/cancers16244283

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication